Semi-Annual Changes to the NASDAQ Biotechnology Index
November 12 2010 - 8:05PM
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced today the
results of the semi-annual re-ranking of the NASDAQ Biotechnology
Index® (Nasdaq:NBI), which will become effective prior to market
open on Monday, November 22, 2010.
The following five securities will be added to the Index: AVI
BioPharma, Inc. (Nasdaq:AVII), Avanir Pharmaceuticals, Inc.
(Nasdaq:AVNR), Caliper Life Sciences, Inc. (Nasdaq:CALP), Ironwood
Pharmaceuticals, Inc. (Nasdaq:IRWD), and Ardea Biosciences, Inc.
(Nasdaq:RDEA).
The Index is designed to track the performance of a set of
NASDAQ-listed securities that are classified as either
biotechnology or pharmaceutical according to the Industry
Classification Benchmark (ICB). The NASDAQ Biotechnology Index is
re-ranked semi-annually in May and November. For more information
about the NASDAQ Biotechnology Index, including detailed
eligibility criteria, visit https://indexes.nasdaqomx.com/.
As a result of the re-ranking, the following security will be
removed from the Index: XOMA Ltd. (Nasdaq:XOMA).
The NASDAQ Biotechnology Index is the basis for the iShares
Nasdaq Biotechnology IndexSM Fund (Nasdaq:IBB), which seeks
investment results that correspond generally to the price and yield
performance, before fees and expenses, of the NASDAQ Biotechnology
Index. In addition, options based on the NASDAQ Biotechnology Index
and the iShares Nasdaq Biotechnology Index Fund trade on various
exchanges.
About NASDAQ OMX Global Index Group
NASDAQ OMX Global Index Group is engaged in the design,
development, calculation, licensing, and marketing of NASDAQ OMX
Indexes. NASDAQ OMX Global Index Group specializes in the
development of indexes focusing on NASDAQ OMX's brand themes of
innovation, technology, growth, and globalization. NASDAQ OMX
Global Index Group also provides custom index services and design
solutions as a third-party provider to selected financial
organizations. For more information about NASDAQ OMX indexes, visit
www.nasdaq.com/indexes.
About NASDAQ OMX Group
The NASDAQ OMX Group, Inc. is the world's largest exchange
company. It delivers trading, exchange technology and public
company services across six continents, with approximately 3,600
listed companies. NASDAQ OMX offers multiple capital raising
solutions to companies around the globe, including its U.S.
listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX
First North, and the U.S. 144A sector. The company offers trading
across multiple asset classes including equities, derivatives,
debt, commodities, structured products and exchange-traded funds.
NASDAQ OMX technology supports the operations of over 70 exchanges,
clearing organizations and central securities depositories in more
than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not
legal entities but describe the common offering from NASDAQ OMX
exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn,
Riga, and Vilnius. For more information about NASDAQ OMX, visit
http://www.nasdaqomx.com. Please follow NASDAQ OMX on Facebook
(http://www.facebook.com/pages/NASDAQ-OMX/108167527653) and Twitter
(http://www.twitter.com/nasdaqomx).
The ETFs set forth above are not issued, endorsed, sold, or
promoted by NASDAQ OMX. NASDAQ OMX makes no
warranties and bears no liability with respect to the
ETFs.
The Industry Classification Benchmark ("ICB") is jointly owned
by FTSE International Limited ("FTSE") and Dow Jones & Company,
Inc.
FTSETM is a trademark of the London Stock Exchange Plc and The
Financial Times Limited and is used by FTSE International Limited
under license.
"Dow Jones" and "DJ" are trademarks of Dow Jones & Company
Inc.
The iShares Funds are distributed by SEI Investments
Distribution Co. ("SEI"). BlackRock Fund Advisors ("BFA") serves as
the investment advisor to the Funds. BFA is a subsidiary of
BlackRock Institutional Trust Company, N.A., neither of which is
affiliated with SEI. For a prospectus, call 1-800-Ishares
(1-800-474-2737), or by viewing or downloading a prospectus at
http://www.ishares.com.
IShares are not FDIC Insured.
Have No Bank Guarantee.
May Lose Value.
NDAQG
CONTACT: The NASDAQ OMX Group, Inc.
Media Contact:
Wayne Lee
+1.301.978.4875
Wayne.D.Lee@NASDAQOMX.Com
Issuer and Investor Contact:
Lisa Chaney
+1.301.978.8281
Lisa.Chaney@NASDAQOMX.Com
Avi Biopharma (NASDAQ:AVII)
Historical Stock Chart
From May 2024 to Jun 2024
Avi Biopharma (NASDAQ:AVII)
Historical Stock Chart
From Jun 2023 to Jun 2024